Werewolf Therapeutics Inc

Werewolf Therapeutics Inc

HOWL

Market Cap$88.72M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Werewolf Therapeutics IncWerewolf Therapeutics Inc-1.6--85%-0.5
$1.61

Current Fair Value

85.6% upside

Undervalued by 85.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$88.72 Million
Enterprise Value$14.81 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.05
Beta0.46
Outstanding Shares43,521,406

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.64
PEG-1.62
Price to Sales-
Price to Book Ratio0.87
Enterprise Value to Revenue4.37
Enterprise Value to EBIT-0.23
Enterprise Value to Net Income-1
Total Debt to Enterprise2.5
Debt to Equity0.51

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Werewolf Therapeutics Inc

28 employees

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is leveraging its proprietary PRE...